Sign in

CIK 0001658551 · Non-accelerated filer<br>Smaller reporting company

Amylyx Pharmaceuticals, Inc.

Sign in to watch
Ticker
AMLX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
464600503
Phone
617-682-0917
Business address
55 CAMBRIDGE PARKWAY, SUITE 6W, CAMBRIDGE, MA, 02142
  1. 144 Insider Sale of Securities
  2. 144 Insider Sale of Securities
  3. 144 Insider Sale of Securities
  4. 10-Q Report Quarterly Report
  5. 8-K Event Results of operations
  6. 4 Planned sale Director sold 30,000 shares at $27.70 ($830,904)
  7. 144 Insider Sale of Securities
  8. 4 Open-market sale Chief Medical Officer sold 10,028 shares at an average $32.40 ($324,868)
  9. 4 Open-market sale Chief Financial Officer sold 10,810 shares at an average $32.36 ($349,821)
  10. 4 Open-market sale Chief Legal Officer sold 9,536 shares at an average $32.46 ($309,506)
  11. 4 Open-market sale Co-Chief Executive Officer sold 30,464 shares at an average $32.18 ($980,263)
  12. 4 Open-market sale Co-Chief Executive Officer sold 30,464 shares at an average $32.19 ($980,504)
  13. 144 Insider Sale of Securities
  14. 144 Insider Sale of Securities
  15. 144 Insider Sale of Securities
  16. 144 Insider Sale of Securities
  17. 144 Insider Sale of Securities
  18. 8-K Event Material agreement
  19. 4 Option exercise Director acquired 50,000 shares (option exercise)
  20. 4 Grant or award Chief Financial Officer acquired 22,807 shares (grant or award)

Page 1 of 23 · 443 filings